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The research field on extracellular vesicles (EV) has rapidly expanded in recent years due to
the therapeutic potential of EV. Adipose tissue human mesenchymal stem cells (ASC) may
be a suitable source for therapeutic EV. A major limitation in the field is the lack of standard-
ization of the challenging techniques to isolate and characterize EV.The aim of our study was
to incorporate new controls for the detection and quantification of EV derived from ASC and
to analyze the applicability and limitations of the available techniques. ASC were cultured in
medium supplemented with 5% of vesicles-free fetal bovine serum.The EV were isolated
from conditioned medium by differential centrifugation with size filtration (0.2µm). As a
control, non-conditioned culture medium was used (control medium).To detect EV, electron
microscopy, conventional flow cytometry, and western blot were used. The quantification
of the EV was by total protein quantification, ExoELISA immunoassay, and Nanosight.
Cytokines and growth factors in the EV samples were measured by multiplex bead array
kit. The EV were detected by electron microscope. Total protein measurement was not
useful to quantify EV as the control medium showed similar protein contents as the EV
samples. The ExoELISA kits had technical troubles and it was not possible to quantify the
concentration of exosomes in the samples. The use of Nanosight enabled quantification
and size determination of the EV. It is, however, not possible to distinguish protein aggre-
gates from EV with this method. The technologies for quantification and characterization
of the EV need to be improved. In addition, we detected protein contaminants in the EV
samples, which make it difficult to determine the real effect of EV in experimental mod-
els. It will be crucial in the future to optimize design novel methods for purification and
characterization of EV.
Keywords: extracellular vesicles, mesenchymal stem cells, differential centrifugation, flow cytometry, electron
microscopy, nanosight
INTRODUCTION
Extracellular vesicles (EV) are lipid bilayer particles coming either
from the inside of a cell or formed directly from its cell mem-
brane, and excreted to the extracellular medium. EV participate
in cell-to-cell communication by transfer of proteins, bioactive
lipids, and nucleic acids (1). The term EV includes exosomes
(30–100 nm), microvesicles (100–1000 nm), and apoptotic bod-
ies (50–5,000 nm) (2). Apoptotic bodies are shed from dying cells,
while microvesicles are shed from the plasma membrane of viable
cells. On the contrary, exosomes are of endocytic origin and are
released when multivesicular bodies fuse with the plasma mem-
brane and release their intraluminal vesicles as exosomes to the
extracellular milieu (3). Exosomes have been defined based on
size, density (1.12–1.19 g/ml), and expression of specific biomark-
ers (e.g., tetraspanins, annexin, and heat shock proteins) (4). Due
to the heterogeneity of the various types of vesicles, it has been
suggested to call them collectively EV.
Almost all cell types release EV both under physiological and
pathological conditions, such as during cell activation, stress, and
apoptosis (5). Recent data indicate that EV have the capacity to
modulate immune responses (6) and facilitate tissue regeneration
(7). EV are therefore seen as potential therapeutic agents. Adipose
tissue-derived mesenchymal stem cells (ASC) may be a suitable
source for therapeutic EV. ASC can be easily isolated from adipose
tissue obtained by liposuction and expanded manifold in vitro (8).
Their immunomodulatory properties have proven to be beneficial
in the treatment of autoimmune diseases and inhibition of allo-
responses after transplantation (9, 10). It has been demonstrated
that EV released from ASC may mimic the beneficial effect of ASC
treatment (11).
The isolation of EV is a challenging procedure. They have been
successfully isolated from supernatant of cell culture and different
body fluids (12). The most widely applied method for concentrat-
ing and purifying EV is isolation by differential centrifugation.
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This method consists of a number of centrifugations, which
sequentially increase in speed and time, and thus, sequentially
pellet smaller particles (12, 13). Although most studies make
use of this method for the isolation of EV, vesicle recovery, and
contamination cannot be reliably controlled in the separation
process because high-speed centrifugation pellets not only EV
but also proteins aggregates, lipoprotein particles, and other con-
taminants (14). Discrepancies within differential centrifugation
protocols lead to inconsistencies in the isolated material, and may
explain the different biological effects of EV reported by different
research groups (15, 16).
In addition to the difficulties of isolating pure EV, progress in
EV research is hampered by sub-optimal quantification methods.
Due to their small size, EV are below the detection range of con-
ventional quantification methods used for cells. In recent years,
various optical and non-optical methods have been developed
or adapted for the assessment of EV quantity, size, and features.
Further optimization and standardization of these protocols are
important for development of the field (17).
In the present study, we isolated EV from ASC conditioned
medium by ultracentrifugation and employed multiple methods
for the detection and quantification of single vesicles: transmis-
sion electron microscopy (TEM), conventional flow cytometry,
nanoparticle tracking analysis (NTA), ELISA immunoassay, and
total protein quantification.
The aim of our study was to incorporate new controls for
the detection and quantification of EV derived from ASC and
to analyze the applicability and limitations of the available
techniques.
METHODS
ISOLATION AND CULTURE OF HUMAN SUBCUTANEOUS ASC
Subcutaneous adipose tissue from healthy donors that became
available as a waste product during the kidney donation pro-
cedure was collected after obtaining written informed con-
sent, as approved by the Medical Ethical Committee of the
Erasmus University Medical Centre Rotterdam (protocol no.
MEC-2006-190). The tissue was collected in minimum essential
medium-α (MEM-α) (Sigma-Aldrich, St Louis, MO, USA) sup-
plemented with penicillin (100 IU/ml), streptomycin (100µg/ml)
(1% P/S; Lonza, Verviers, Belgium), and 2 mM l-glutamine
(Lonza) and stored at 4°C for 3–16 h. ASC were isolated as
described previously (18). Cultures were kept at 37°C, 5% CO2,
and 95% humidity and refreshed twice weekly with MEM-
α with 1% P/S, and 15% fetal bovine serum (FBS; Lonza).
At 90% confluency, adherent cells were removed from culture
flasks by incubation in 0.05% trypsin–EDTA (Life Technolo-
gies, Bleiswijk, Netherlands) at 37°C and cells were used for
experiments described below or frozen at −150°C until fur-
ther use. ASC were used for experiments between passages 2
and 5 and their phenotypic markers and osteogenic and adi-
pogenic potential were tested as described before (19). ASC from
five donors were used in the experiments. Cell culture super-
natants (SN) were processed using MycoAlert®kit, according to
the manufacturer’s instructions (Lonza), to detect Mycoplasma
contamination.
ISOLATION OF EV BY DIFFERENTIAL CENTRIFUGATION
Supernatant collection
Supernatants were collected from conditioned medium of ASC
cultures of passage 3–5 at 80% confluence (~1× 106 cells) 24 h
after refreshment with 20 ml of medium (MEM-α containing 5%
FBS, 2 mM l-glutamine, 100 U/ml penicillin, and 100µg/ml strep-
tomycin). Prior to use, the FBS was centrifuged at 100,000× g for
18 h to remove the possible contaminating EV. In indicated exper-
iments, ASC were cultured in the presence of recombinant human
IFN-γ (10 ng/ml) for 3 days, washed with PBS, and cultured with
conditioned medium for 24 h. After that, supernatant was col-
lected. Non-conditioned culture medium was used as control
(control medium).
Isolation of EV
Differential centrifugation is the most common method used
for the isolation of EV from SN (12, 13). First, cells were
removed by pelleting by centrifugation at 300× g for 30 min.
Subsequently, the supernatant was filtered (pore size 0.2µm) to
remove large particles. Filtered SN were then ultracentrifuged at
100,000× g for 2 h. Some of the pellets were washed with PBS
and again pelleted at 100,000× g for 2 h to remove protein con-
tamination (Figure 1). All the samples were ultracentrifuged in
polyallomer Quick-Seal centrifuge tubes (25 mm× 89 mm, Beck-
man Coulter) that have a volume of 39 ml. A Beckman Coul-
ter ultracentrifuge (Beckman Coulter Optima L-90K ultracen-
trifuge; Beckman Coulter, Fullerton, CA, USA) was used with
a fixed angle rotor type 70ti. EVs were collected in 200µl of
filtered PBS.
DETECTION METHODS
Electron microscopy
Extracellular vesicles samples used for electron microscopy were
re-suspended in PBS and 5µl was loaded onto formvar carbon-
coated grids (Ted Pella Inc., Redding, CA, USA). Samples were
fixed in 2% paraformaldehyde and 2.5% glutaraldehyde and con-
trasted in 2% uranyl acetate. Samples were examined in a DSM
940 A electron microscope (Carl Zeiss NTS, Jena, Germany).
Vesicles were measured with the iTEM software (Olympus-SiS,
Münster, Germany).
Western blot
After ultracentrifugation of control medium and conditioned
medium, two fractions (pellets and SN) were collected. The pel-
lets were solubilized (50µl) and SN were diluted (1:2) in Laemmli
buffer. SN were used as technical control. The samples were pre-
heated at 60°C for 15 min. SDS/PAGE was carried out on a 4–20%
polyacrylamide gel, and proteins were transferred to Immobilon®-
P membranes (Millipore, Amsterdam, The Netherlands). The
membranes were blocked in 5% milk and were probed overnight
at 4°C with CD9 antibody (Santa Cruz biotechnology). After three
washes in TBS-Tween 20, membranes were incubated with the sec-
ondary antibody (Thermo Scientific, Rockford, IL, USA) for 1 h
and washed again. For visualization, blots were exposed to Pierce®
enhanced chemiluminescent substrate and measured by Uvitec
Alliance 2.7 (Cambridge, UK).
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FIGURE 1 | Flow chart for the EV purification procedure based on
differential ultracentrifugation. The speed and the length of each
centrifugation step are indicated at the central line of the arrows. After each
the first step, pellet is discarded, and the supernatant is kept for the next
step. In contrast, after the two 100,000×g centrifugations, pellets are
kept, and the supernatants are discarded.
Flow cytometric analysis of EV
To obtain fluorescent EV, ASC were labeled with the green
fluorescent cell dye PKH-67 according to the manufacturer’s
instructions (Sigma). Immediately prior to staining, PKH-67 dye
was prepared and added to 1 ml of ASC in suspension (2× 106
cells). After incubation at 25°C for 10 min, the staining reaction
was stopped by adding an equal volume of FBS. Labeled ASC
were replated into flaks (seeding density= 1× 106 cells/175 cm2).
After 24 h, the cells were attached to the flask, the supernatant was
then removed, and the cells were washed with PBS. Conditioned
medium was added and collected after 24 h. EV from non-labeled
ASC were used as control.
The samples were acquired with a FacsCanto II (Becton Dickin-
son) and run on the “LOW” setting. The analysis was realized with
a SSC/Fluorescent Dot Plot to avoid the error due to FSC detection
limit. To compare the detection sensitivity of the flow cytometer,
SPHEROTM Nano Yellow Fluorescent Particles (Spherotech, Lake
Forest, IL, USA) were used.
QUANTIFICATION METHODS
Total protein analysis
Various volumes of cell culture SN were centrifuged (10, 20, 30,
40, and 80 ml) to collect samples with an increasing dose of EV.
The number of cells to produce the different amount of volume
was ~0.5× 106, 1× 106, 1.5× 106, 2× 106, and 4× 106. As con-
trol, control medium was used. EV were prepared in two ways. In
the first protocol, protein contents of EV were released by pro-
tein extraction protocol, isolated EV, or control medium were
re-suspended in 200µl of RIPA buffer (Sigma-Aldrich) with pro-
tease inhibitors cocktail (Sigma-Aldrich), and then sonicated for
5 min, three times, vortexing in between. In the second proto-
col, no protein extraction was performed and the samples were
collected in 200µl of PBS.
Protein contents were measured using a BCA protein assay
kit (Thermo Scientific Pierce, Rockford, IL, USA). BSA standard
or samples (25µl) were transferred to a 96 well plate to which
200µl working reagent was added (working reagent 50:1 ratio of
assay reagents A and B). The plate was incubated for 30 min at
37°C, before being analyzed with a spectrophotometer at 562 nm
(Victor3, Perkin-Elmer, Waltham, MA, USA).
ExoELISA
To generate samples with increasing concentrations of EV, the
protocol described in total protein quantification paragraph was
performed. Exosome concentrations in the EV samples were deter-
mined using commercially available ELISA kits (ExoElisa) pur-
chased from System Biosciences (SBI) (Mountain View, CA, USA).
According to the manufacturer’s instructions, after isolation, the
EV were diluted in 200µl of exosome binding buffer and 50µl of
prepared protein standards and EV sample were directly immobi-
lized onto the wells of the microtiter plate. The detection antibody
was added to the wells for binding to specific antigen (tetraspanins:
CD63, CD9, CD81) protein on the exosomes. A horseradish per-
oxidase enzyme linked secondary antibody was used for signal
amplification. A colorimetric substrate was used for the assay read
out. The results were quantified by a microtiter plate reader at
450 nm absorbance and sample readings were extrapolated against
a concurrently run standard curve.
Nanoparticles tracking analysis
Analysis of absolute size distribution of EV was performed using
NanoSight LM10 (NanoSight Ltd., Minton Park, UK). With NTA,
particles are automatically tracked and sized based on Brown-
ian motion and the diffusion coefficient. After isolation, the EVs
were diluted in 1 ml of filtered PBS. Control medium and fil-
tered PBS were used as controls in this technique. The NTA
measurement conditions were temperature 23.75± 0.5°C; viscos-
ity 0.91± 0.03 cP, frames per second 25, measurement time 60 s.
The detection threshold was similar in all the samples (2 multi).
Three recordings were performed for each sample.
DETERMINATION OF CYTOKINES AND GROWTH FACTORS IN THE EV
SAMPLES
Multiplex bead array kits
To analyze the protein composition of EV samples, a multi-
plex bead array kit containing EGF, FGF2, G-CSF, IFN-γ, IL-10,
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IL-12p70, sCD40L, IL-1RA, IL-1b, IL-8, IP-10, MIP1a, and VEGF
was used. Conditioned medium (40 ml) from 2× 106 ASC was
collected to perform the EV isolation. EVs were diluted in 200µl
of filtered PBS and 25µl was added to a 96-wellplate utilizing a
custom X-cytokine Milliplex MAP Human Cytokine/Chemokine
Magnetic Bead Panel (Millipore Corp., Billerica, MA, USA) fol-
lowing the kit-specific protocols provided by Millipore. Analytes
were quantified using a Magpix analytical test instrument, which
utilizes xMAP technology (Luminex Corp., Austin, TX, USA), and
xPONENT 4.2 software (Luminex). xMAP technology uses fluo-
rescent coded magnetic microspheres coated with analyte-specific
capture antibodies to simultaneously measure multiple analytes in
a specimen. Concentrations of cytokines (pg/ml) were determined
on the basis of the fit of a standard curve for mean fluorescence
intensity versus pg/ml.
RESULTS
ASC CHARACTERIZATION
ASC demonstrated a spindle-shaped morphology in culture.
When cultured under the appropriate conditions the cells were
capable of differentiating into the osteoblastic and adipogenic
lineages, characterized by the deposition of calcified nodules
and production of lipid-filled vesicles, respectively (Figure 2A).
Flow cytometric analysis demonstrated ASC to be negative for
CD34 and CD45, but positive for the ASC markers CD73,
CD90, and CD105 (Figure 2B). All the SN were negative for
Mycoplasma.
DETECTION OF EV IN CONDITIONED MEDIUM AND CONTROL MEDIUM
Electron microscopy and western blot
To confirm the presence of EV derived from ASC in conditioned
medium, samples were processed for electron microscopy. Control
medium was used to determine vesicle contamination from the
vesicle-depleted serum. The analysis showed the presence of nano-
sized vesicles in both conditioned medium and control medium
(Figures 3A,B). EV had a rounded shaped, and the diameter was
between 40–120 nm, based on the smallest and greatest observed
vesicles in several micrographs (Figure 3C). The distribution of
the EV in the sample was not homogeneous, some empty fields,
and others with aggregated EV were observed.
Western blot analysis revealed the presence of human CD9
marker in the conditioned medium pellet (Figure 3D). Control
FIGURE 2 | (A) Bright-field image of ASC in culture (left), osteogenic (middle), and adipogenic (right) differentiation of ASC. ASC were stained by von Kossa
staining for calcified nodules (black) and by oil red O for lipid-filled vesicles (red), respectively. (B) ASC were characterized by flow cytometry. ASC were negative
for CD34 and CD45, and positive for the ASC markers CD73, CD90, and CD105. Closed histograms: unstained cells, open histograms: stained cells.
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FIGURE 3 | Electron micrographs analyses of EV from control medium (A) and conditioned medium (B). Structural analysis of ASC-derived EV shows the
presence of vesicles in the size range of 40–120 nm. Scale bar 500 nm (C). Representative western blot analysis of exosome marker (CD9) in control medium
and conditioned medium (D).
medium was negative for the expression of human CD9,suggesting
that the EV detected in the medium were FBS origin.
Flow cytometry
Fluorescent nanobeads were acquired without SSC-A threshold
and due to the noise, the nanobeads could not be detected
(Figure 4A). Using a SSC threshold of 200 arbitrary units, the
lower sensitivity of the instrument was established, and a part of
the noise was eliminated. With this configuration, the nanobeads
were detected (Figure 4B). But, fluorescent particles below the
threshold cannot be analyzed.
Extracellular vesicles without fluorescence were used as neg-
ative control (Figure 4C) and with fluorescence to know their
location in the SSC/Fluorescent dot plot (Figure 4D). The major-
ity (>90%) of the fluorescent EVs were at noise area, and resolving
the noise from Fluorescent EV was not possible.
QUANTIFICATION OF EV IN SUPERNATANTS
Protein quantification
One of the main methods of quantifying the number of EV is
to determine the protein contents of EV. To do this, we isolated
EV from increasing volumes of conditioned medium and con-
trol medium. The pellets were prepared with and without protein
extraction.
Analyzing the protein concentration in the pellets without pro-
tein extraction, we observed that there was no difference between
control medium and EV samples (Figure 5A). After protein extrac-
tion, the difference between pellet from conditioned medium and
control medium at each concentration point was not significant
(1.5± 0.9µg/ml protein) (Figure 5B).
ExoELISA
To quantify the exosome concentration in the EV samples, three
ELISA kits were used to detect the tetraspanin proteins CD9, CD81,
and CD63.We encountered some technical problems with the kits.
The main issue was that the standard protein of the kits produces
a low-intensity signal. The absorbance at 450 nm of the maximum
concentration of the standard protein was 0.2± 0.1, whereas the
expected values should be ~1.5. In the CD63 and CD81 ELISA,
our samples showed a signal higher than the standard curve but
the results, at duplicated wells, had a large SD.
NANOPARTICLES TRACKING ANALYSIS
Before analysis of the samples by NTA, we checked that salts
aggregates from the PBS did not produce any background and
the equipment was free of any contaminant particles from
other users. Control medium showed a considerable num-
ber of particles (2.5× 108± 0.5× 108 particles/ml). However,
the concentration of the EV from conditioned medium was
higher than control medium (5× 108± 0.4× 108 particles/ml,
p< 0.05). It was observed that before the washing step,
conditioned medium showed a higher number of particles
(28.5× 108± 3× 108 particles/ml) than after this step (p< 0.01).
Figure 6A is a representative screen shot of the NTA videos for
control medium, conditioned medium after/before washing step.
With respect to the size, the EV population was homogenous. NTA
estimated the size of the EV between 90 and 150 nm (Figure 6B).
DETECTION OF CYTOKINES IN EV SAMPLES
To determine the cytokines or growth factor present in
the EV samples, a multiplex bead array kit was used. IL-8
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FIGURE 4 | Representative analysis of nano-fluorescent beads and EV by flow cytometry. Scatter (SSC) and fluorescent resolution of nanobeads with
various sizes (A) without SSC threshold, and (B) with SSC threshold. (C) Non-fluorescent EV and (D) fluorescent EV plot.
(16.9± 7.1 pg/ml) and VEGF (78.8± 21.4 pg/ml) were detected
in the samples (Figure 7A). In an additional experiment, EVs
were isolated from conditioned medium of ASC stimulated
with IFN-γ. Elevated concentrations of G-CSF (16.1± 2.4 pg/ml),
IFN-γ (604.8± 112.3 pg/ml), IL-8 (15± 1.7 pg/ml), IP-10
(550.7± 98.4 pg/ml), and VEGF (50± 7.1 pg/ml) were found
(Figure 7B). In the control medium, no factors were detected.
The concentrations of these factors were significantly lower when
the EVs were washed with PBS. No significant levels of EGF,
FGF2, IL-10, IL-12p70, sCD40L, IL-1RA, IL-1b, and MIP1a were
detected.
DISCUSSION
In the present study, EV were isolated from ASC and their
purity and quantity determined with currently available tech-
niques. The limitations of these methods have been summarized
in Table 1.
Working with EV requires healthy cell cultures. One of the most
important requirements for working with EV is to verify that the
cell culture is Mycoplasma free. We used a colorimetric test to
demonstrate that our ASC culture had no Mycoplasma contam-
ination. Several authors showed a potential immunosuppressive
mechanism of mycoplasmas-infected cells through the release
of vesicles (20). They reported that a few dendritic cells, which
produced EV fractions with potent capacity to stimulate B cell, but
not T cell proliferation, contained Mycoplasma isolated along with
vesicles (21). Despite the importance of detecting Mycoplasma
contamination in studies about the immunomodulatory capacity
of the EV, this is not standard practice.
The first challenge of working with EV is the isolation of
these particles. Many different procedures to obtain EV have been
described in the literature (22) and they potentially obtain EV
with different properties and compositions (23). Differential cen-
trifugation is the most common method to purify EV from body
fluids and conditioned medium. Several protocols are available,
generally it consists of multiple steps: first a low speed spin, fol-
lowed by high-speed spin at 100,000× g. To obtain more purified
EV and eliminate protein contaminations, the pellet is washed
again in a large volume of PBS and centrifuge an additional time
at 100,000× g. The EV isolation from ASC presents the incon-
venience that it is necessary to use serum for the cell culture.
Several authors have demonstrated that serum deprivation pro-
duces changes in the expression pattern of markers in ASC (24)
and in the secretome (25). To avoid contamination with EV from
the serum, it has been described that serum should to be ultra-
centrifuged before added to ASC culture. But, we also suggest
that non-conditioned medium (control medium) needs to be
prepared with the same protocol as the conditioned medium.
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FIGURE 5 | Extracellular vesicle protein concentration in the control
medium and conditioned medium; BCA assay using a protocol
without extraction of EV protein (A), and with protein extraction (B).
With this control, the possible background of the medium in
the detection and quantification techniques could be detected.
In order to confirm the presence of EV, conditioned medium,
and control medium were analyzed by electron microscopy. Both
preparations contained a population of EV with a size range
between 40 and 150 nm. This technique provides direct evidence
for the presence of EV, but it is of limited use for concentra-
tion measurements. The analysis of the western blot confirmed
the presence of CD9 positive exosomes in the samples, but with
this method, it is not possible to obtain global information
about all the types of EV contained in the samples. It would
be necessary, a common marker for exosomes and microvesi-
cles, because both precipitate with the differential centrifugation
protocol (13).
Flow cytometry could be a powerful method for qualita-
tive and quantitative characterization of EV. The EV are usually
labeled with fluorescent membrane intercalating dye PKH-67 to
be detected by flow cytometry. For removal of excess of PKH-
67, EVs are subjected to gradient centrifugation on sucrose (26).
We decided to not use this technique because only EV with a
particular density but not the total population of EV can be
obtained by gradient centrifugation on sucrose. This subpop-
ulation would differ from the EV isolated with the differential
centrifugation protocol. To resolve this technical issue, ASC were
labeled with PKH-67, so that secreted EV would be PKH-67
positive (27). The fluorescent EV were isolated by differential cen-
trifugation and analyzed in a conventional BD FacsCanto II with
a fluorescent threshold. Positive fluorescent particles were shown
in a SSC/Fluorescent plot. In our experimental conditions, the
fluorescence signal was overlapping with the noise, making con-
ventional flow cytometry unsuitable for the quantification and
characterization of EV.
Various methods have been developed or adapted for the assess-
ment of EV quantity (17). Optimization and standardization
of protocols remain an important task. One of the most used
techniques to quantify the EV is the quantification of the total
proteins of the EV with BCA protein assay. Two protocols for
the quantification of the EV are available in the literature, one
with EV protein extraction (14), and one without (12). How-
ever, protein measurements of EV-containing pellets are inade-
quate to quantify EV as pellets from a high-speed spin contain
proteins complexes/aggregates, lipoprotein particles, and other
contaminants.
ELISA for tetraspanin proteins has the advantage of measur-
ing the concentration of EV specific protein as it is based on EV
specific antigen–antibody immune reaction. This reaction would
confer specificity to measurement of the EV. None of the cur-
rently used protocols of EV purification are likely to separate
the different types of vesicles (13) and there is not a common
marker for all the EV (28). Consequently, we could only analyze
some vesicle subsets like exosomes, because they express similar
membrane proteins (tetraspanins) (29), but it is not possible to
know the total concentration of the EV in our samples with the
ELISA. Additionally, the commercial ExoELISA that is available
for measuring exosome concentrations showed several technical
troubles.
Nanoparticle tracking analysis is an optical particles tracking
method for obtaining concentration and size distribution of EV
populations and is capable of detecting single particles with a
diameter as low as 50 nm (2). We quantified control medium and
conditioned medium before and after washing step with NTA, to
know whether this step of the protocol reduced the yield of EV.
Some contaminant particles in control medium were observed,
most likely coming from the serum. This contamination could
alter the measured concentration of the samples. Respect to the
washing step, a loss of particles was observed after this step but,
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FIGURE 6 | Nanoparticle tracking analysis (NTA) of conditioned medium from ASC culture. (A) Screen shots from NTA videos of control medium,
conditioned medium, and conditioned medium before washing step in PBS. (B) Size distribution graph of EV from ASC with a peak at 115 nm.
FIGURE 7 | Concentrations of cytokines and growth factors quantified by multiplex bead array kit in EV samples from control medium and
conditioned medium. Results are expressed as pg/ml. (A) EV from ASC; (B) EV from IFN-γ pretreated ASC.
with NTA, it is not possible to determine whether the loss of
particles during the washing step represents the loss of protein
aggregates or EV (30).
Due to the difficulty to obtain EV without protein contam-
ination by differential centrifugation (16), we decided to use a
multiplex bead array kit to analyze the presence of a range of
cytokines and growth factor produced by the ASC in EV sam-
ples. Factors like VEGF and IL-8 were detected. ASC stimulated
with IFN-γ secreted more factors (IP-10, IFN-γ, G-CSF) than ASC
under normal conditions (31) and these factors were also found in
the EV samples. The washing step decreased the concentration of
these factors but did not eliminate them completely. These factors
were not present in the control medium indicating that they were
released by ASC. We can speculate about the position of these fac-
tors, they could be shuttled in the membrane of the EV or they
could be contaminant factors that precipitate with the EV. Due to
that these factors can be detected in ASC SN, without differential
centrifugation protocol, with a concentration higher than in the
EV samples, it is more likely to be contaminating proteins from
the ASC.
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Table 1 | Summary of main characteristics of the EV detection and
quantification methods.
Characteristics
DETECTION METHODS
Electron microscopy Direct evidence for the presence of EV
Assessments of morphology and size
No quantification of EV
Need an expert in electron microscopy
Flow cytometry Detection of EV bigger than 300 nm
Low detection threshold (only analysis of large EV)
Western blot Detection of specific EV subset
QUANTIFICATION METHODS
BCA protein assay Easy protocol
Low-cost method
No specific information about EV concentration
ExoELISA (SBI) Specific for exosome proteins
Technical troubles. Unreliable
NTA Analysis of absolute concentration of particles
Assessment of the particles size
No distinguishment of EV from aggregated protein
CONCLUSION
The current technologies for isolation, quantification, and char-
acterization of EV need to be improved. The control medium
showed the background that is produced by the medium in the
detection and quantification techniques and even could be neces-
sary to determine the effects that the vesicles from the serum could
have in functional assays. Measurement of soluble factors in EV
samples should be incorporated in the studies to obtain reliable
results about the effects of the EV.
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